Target intelligence / Profile preview

MARVEL domain-containing protein 3 (MARVELD3)

Target
MARVELD3
Molecular classification
Other (specifically, tight junction–associated MARVEL protein, also known as TAMP), Transmembrane protein
01

Overview

MARVEL domain-containing protein 3 (MARVELD3) is a member of the tight junction–associated MARVEL protein (TAMP) family, which includes occludin and tricellulin[1]. It is a transmembrane protein containing a conserved MARVEL domain, characterized by four transmembrane helices[1][4]. MARVELD3 localizes to epithelial tight junctions, where it contributes to the regulation of paracellular ion permeability and epithelial barrier function[1][2][5]. Although MARVELD3 can partially compensate for the loss of other TAMPs, it has distinct, nonredundant roles in tight junction assembly and maintenance[1]. MARVELD3 is expressed across multiple epithelial tissues and its abnormal expression has been implicated as a potential prognostic marker in various cancers, including oral squamous cell carcinoma and hepatocellular carcinoma[2]. There are currently no approved drugs directly targeting MARVELD3, and no known safety liabilities associated with modulating this protein.

Other names
MARVEL domain-containing protein 3MARVELD3MRVLDC3MARVD3MARVEL (membrane-associating) domain containing 3
02

Biological functions

Maintenance of epithelial tight junction integrityRegulation of epithelial cell proliferation, migration, and survivalRegulation of paracellular ion conductivityInteraction with other tight junction proteins (occludin, tricellulin)
03

Disease associations

Cancer (evidence for regulatory role in colon, pancreatic, hepatocellular carcinoma, and oral squamous cell carcinoma)Potentially involved in epithelial barrier dysfunction
04

Biomarkers

High expression associated with prognosis in certain cancers, e.g., oral squamous cell carcinoma

Beyond the preview

Go deeper on MARVEL domain-containing protein 3 (MARVELD3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MARVEL domain-containing protein 3 (MARVELD3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call